课题基金 / 基金详情

Language Development Following Early Focal Brain Injury

Language Development Following Early Focal Brain Injury
早期局灶性脑损伤后的语言发展
批准号:
7021423
负责人:
DORIS A TRAUNER
金额:
$33.77万
依托单位国家:
美国
项目类别:
财政年份:
2004
资助国家:
美国
项目状态:
已结题
起止时间:
2004-04-01 至 2009-02-28

项目摘要

项目成果

DORIS A TRAUNER的其他基金

相似基金

相关文献

中文摘要
翻译
描述(由申请人提供):我们建议对从出生到5岁的早期脑损伤与语言发展之间的关系进行前瞻性、纵向研究,基于对先天性左半球或右半球损伤(主要是由于产前或围产期中风)儿童的语言和认知结果的15年研究,使用最先进的结构成像和病变症状映射方法。后者包括我们实验室开发的一种称为基于体素的病变症状映射(VLSM, Bates等人,Nature: Neuroscience, 2003)的新方法,该方法允许行为测量和病变部位之间关系的分级彩色映射,首次应用于病变儿童。新的弥散张量成像(DTI)方法将用于检查可能归因于早期脑损伤和随后重组的连接变化。语言和相关非语言功能的纵向研究将从8个月到60个月进行,这是大部分语言获得的时期,从最初的咿呀学语到掌握语法和话语。我们之前的研究表明,这一时期是一个“可塑性窗口期”,在此期间,大多数早期单侧损伤的儿童开始时都有严重的发育迟缓,但在语言测量上进入正常到低正常的范围。在患有先天性单侧损伤的儿童中,我们将尝试扩展一系列重要和令人惊讶的发现,这些发现涉及与咿呀学语、单词理解、手势、单词生成和语法的初始延迟相关的特定病变部位,并研究早期局灶性脑损伤儿童的语言和视觉空间发展轨迹。里程碑、轨迹、延迟和延迟恢复的神经解剖学相关性将基于三维病变重建、VLSM和DTI建立。对于所有患有脑损伤的儿童,将在两个时间点进行扫描:进入研究时(6至36个月)和5岁时。这两个数据点将允许在受试者内部分析系统的初始状态,其中神经解剖学的任何变化可能与病变类型和/或语言发展成功或失败的程度有关。还将对5岁时年龄和性别匹配的对照组进行扫描,以评估由于早期损伤和随后的重组造成的结构变化,这些变化也可能与语言成功的程度和时间有关。从这些研究中获得的新信息将增强我们对发育中的神经系统可塑性相关变化时间的理解,以及定义语言和视觉空间发展中的关联和分离。在这项研究中获得的知识可能形成更有效的干预措施的基础,以帮助改善未来脑损伤儿童的神经发育结果。
英文摘要
DESCRIPTION (provided by applicant): We propose prospective, longitudinal studies of the relationship between early brain injury and language development from birth to age 5, building on 15 years of research on language and cognitive outcomes in children with congenital left- or right hemisphere injuries (due primarily to pre- or perinatal stroke), using state-of-the-art methods for structural imaging and lesion-symptom mapping. The latter include a new method called Voxel-based Lesion Symptom Mapping (VLSM, Bates et al., Nature: Neuroscience, 2003) developed in our laboratories, which permits graded color maps of the relationship between behavioral measures and lesion sites, applied for the first time to children with lesions. New diffusion-tensor imaging (DTI) methods will be used to examine changes in connectivity that may be attributable to early brain injury and subsequent reorganization. Longitudinal studies of language and related non-linguistic functions will be conducted from 8 to 60 months of age, the period in which most of language is acquired, from the first signs of babbling to the mastery of grammar and discourse. Our previous studies suggest that this period is a "window of plasticity", in which most children with early unilateral injuries start with serious delays, but move into the normal to low-normal range on language measures. In children with congenital, unilateral lesions, we will attempt to extend a series of important and surprising findings regarding the specific lesion sites associated with initial delays in babbling, word comprehension, gesture, word production, and grammar, and to examine the trajectories of language and visual spatial development in children with early focal brain damage. Neuroanatomical correlates of milestones, trajectories, delays and recovery from delay will be established based on 3-dimensional lesion reconstruction, VLSM and DTI. For all children with brain injuries, scans will be obtained at two points: on entry into the study (between 6 and 36 months), and at 5 years of age. These two data points will permit within-subject analyses of the initial state of the system with any changes in neuroanatomy that may be related to lesion type and/or to degrees of success or failure in language development. Scans will also be obtained for age- and gender-matched controls at age 5, permitting an assessment of structural alterations due to early injury and subsequent reorganization, alterations which also may correlate with degree and timing of success in language. The new information gained from these studies will enhance our understanding of the timing of changes associated with plasticity in the developing nervous system, as well as defining associations and dissociations in linguistic and visual spatial development. Knowledge gained in this study may form the basis for more effective interventions to help improve neurodevelopmental outcome of children with brain damage in the future.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
CLINICAL TRIAL: CHILDHOOD ABSENCE EPILEPSY: RX, PK-PD-PHARMACOGENETICS
CLINICAL TRIAL: CHILDHOOD ABSENCE EPILEPSY: RX, PK-PD-PHARMACOGENETICS
CLINICAL TRIAL: CHILDHOOD ABSENCE EPILEPSY: RX, PK-PD-PHARMACOGENETICS
CHILDHOOD ABSENCE EPILEPSY: RX, PK-PD-PHARMACOGENETICS
海外基金